Search research articles
Contact Us
Filters
Showing results (591-600 of 690) with videos related to
Page
of 69
Sort By:
Antimicrobial Agents and Chemotherapy
|
June 17, 2020
ATI-2173, a Novel Liver-Targeted Non-Chain-Terminating Nucleotide for Hepatitis B Virus Cure Regimens
Katherine E Squires, Douglas L Mayers, Gregory R Bluemling, et al.
Military Medicine
|
July 27, 2001
Clinical prognosis of patients with early-stage human immunodeficiency virus (HIV) disease: contribution of HIV-1 RNA and T lymphocyte subset quantitation
A E Brown, M J Dolan, N L Michael, et al.
Lancet (London, England)
|
October 25, 2019
Recurrence of breast cancer after regional or general anaesthesia: a randomised controlled trial
Daniel I Sessler, Lijian Pei, Yuguang Huang, et al.
Epidemiology and Infection
|
August 25, 2023
Understanding the disease and economic impact of avirulent avian paramyxovirus type 1 (APMV-1) infection in Great Britain
Scott M Reid, Paul Skinner, David Sutton, et al.
Nature Communications
|
November 10, 2015
Atomic and vibrational origins of mechanical toughness in bioactive cement during setting
Kun V Tian, Bin Yang, Yuanzheng Yue, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 20, 2006
Efficacy of the protease inhibitors tipranavir plus ritonavir in treatment-experienced patients: 24-week analysis from the RESIST-1 trial
Joseph Gathe, David A Cooper, Charles Farthing, et al.
Journal of Virological Methods
|
December 2, 2009
Optimization of allele-specific PCR using patient-specific HIV consensus sequences for primer design
Valerie F Boltz, Frank Maldarelli, Neil Martinson, et al.
Journal of Medicinal Chemistry
|
October 24, 2012
Novel acidic 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor with reduced acyl glucuronide liability: the discovery of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid (AZD8329)
James S Scott, Joanne deSchoolmeester, Elaine Kilgour, et al.
Journal of Clinical and Translational Science
|
September 14, 2023
The RIC Recruitment & Retention Materials Toolkit - a resource for developing community-informed study materials
Stephanie A Mayers, Sarah K Cook, Caitlin Rantala, et al.
Journal of the American Academy of Dermatology
|
March 21, 2021
Clinical mimickers of calciphylaxis: A retrospective study
Colleen K Gabel, Amy E Blum, Josie François, et al.
Page
of 69
Search research articles
Search
Showing results (591-600 of 690) with videos related to
Sort By:
Page
of 69
Antimicrobial Agents and Chemotherapy
|
June 17, 2020
ATI-2173, a Novel Liver-Targeted Non-Chain-Terminating Nucleotide for Hepatitis B Virus Cure Regimens
Katherine E Squires, Douglas L Mayers, Gregory R Bluemling, et al.
Military Medicine
|
July 27, 2001
Clinical prognosis of patients with early-stage human immunodeficiency virus (HIV) disease: contribution of HIV-1 RNA and T lymphocyte subset quantitation
A E Brown, M J Dolan, N L Michael, et al.
Lancet (London, England)
|
October 25, 2019
Recurrence of breast cancer after regional or general anaesthesia: a randomised controlled trial
Daniel I Sessler, Lijian Pei, Yuguang Huang, et al.
Epidemiology and Infection
|
August 25, 2023
Understanding the disease and economic impact of avirulent avian paramyxovirus type 1 (APMV-1) infection in Great Britain
Scott M Reid, Paul Skinner, David Sutton, et al.
Nature Communications
|
November 10, 2015
Atomic and vibrational origins of mechanical toughness in bioactive cement during setting
Kun V Tian, Bin Yang, Yuanzheng Yue, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 20, 2006
Efficacy of the protease inhibitors tipranavir plus ritonavir in treatment-experienced patients: 24-week analysis from the RESIST-1 trial
Joseph Gathe, David A Cooper, Charles Farthing, et al.
Journal of Virological Methods
|
December 2, 2009
Optimization of allele-specific PCR using patient-specific HIV consensus sequences for primer design
Valerie F Boltz, Frank Maldarelli, Neil Martinson, et al.
Journal of Medicinal Chemistry
|
October 24, 2012
Novel acidic 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor with reduced acyl glucuronide liability: the discovery of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid (AZD8329)
James S Scott, Joanne deSchoolmeester, Elaine Kilgour, et al.
Journal of Clinical and Translational Science
|
September 14, 2023
The RIC Recruitment & Retention Materials Toolkit - a resource for developing community-informed study materials
Stephanie A Mayers, Sarah K Cook, Caitlin Rantala, et al.
Journal of the American Academy of Dermatology
|
March 21, 2021
Clinical mimickers of calciphylaxis: A retrospective study
Colleen K Gabel, Amy E Blum, Josie François, et al.
Page
of 69